Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Pratt Whalen currently holds 25,000 shares of Telomir Pharmaceuticals, Inc. (TELO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Pratt Whalen has been a net neutral trader of TELO stock. They have purchased $0 and sold $0 worth of shares.
Matthew Pratt Whalen's most recent insider trade was on May 21, 2026, when they sold 25,000 shares at $0.00 per share.
Matthew Pratt Whalen serves as Executive at Telomir Pharmaceuticals, Inc. (TELO). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Matthew Pratt Whalen holds the position of Executive at Telomir Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Matthew Pratt Whalen has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Matthew Pratt Whalen was on May 21, 2026, when they sold $0 worth of TELO shares. This transaction involved 25,000 shares at N/A per share.
Matthew Pratt Whalen currently owns 25,000 shares of Telomir Pharmaceuticals, Inc. (TELO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Pratt Whalen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Pratt Whalen has 4 Form 4 filings on record as an insider at Telomir Pharmaceuticals, Inc..
Set alerts for Matthew Pratt Whalen and 40,000+ other insiders.